{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T19:27:58Z","timestamp":1740166078289,"version":"3.37.3"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,10,28]],"date-time":"2019-10-28T00:00:00Z","timestamp":1572220800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,28]],"date-time":"2019-10-28T00:00:00Z","timestamp":1572220800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s13760-019-01231-2","type":"journal-article","created":{"date-parts":[[2019,10,28]],"date-time":"2019-10-28T15:03:47Z","timestamp":1572275027000},"page":"503-508","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Cross-sectional evaluation of prescription of valproate and other antiepileptic drugs to pregnant women"],"prefix":"10.1007","volume":"121","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8224-4006","authenticated-orcid":false,"given":"Duygun Alt\u0131nta\u015f","family":"Aykan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6169-8911","authenticated-orcid":false,"given":"Yusuf","family":"Erg\u00fcn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,28]]},"reference":[{"key":"1231_CR1","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.yebeh.2013.09.044","volume":"31","author":"A McGrath","year":"2014","unstructured":"McGrath A, Sharpe L, Lah S, Parratt K (2014) Pregnancy-related knowledge and information needs of women with epilepsy: a systematic review. Epilepsy Behav 31:246\u2013255","journal-title":"Epilepsy Behav"},{"key":"1231_CR2","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s13311-016-0464-0","volume":"13","author":"PB Pennell","year":"2016","unstructured":"Pennell PB (2016) Use of antiepileptic drugs during pregnancy: evolving concepts. Neurotherapeutics 13:811\u2013820. https:\/\/doi.org\/10.1007\/s13311-016-0464-0","journal-title":"Neurotherapeutics"},{"key":"1231_CR3","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1001\/jama.2017.14485","volume":"318","author":"RL Bromley","year":"2017","unstructured":"Bromley RL, Weston J, Marson AG (2017) Maternal use of antiepileptic agents during pregnancy and major congenital malformations in children. JAMA 318:1700\u20131701. https:\/\/doi.org\/10.1001\/jama.2017.14485","journal-title":"JAMA"},{"key":"1231_CR4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1741-4520.2010.00308.x","volume":"51","author":"C Schaefer","year":"2011","unstructured":"Schaefer C (2011) Drug safety in pregnancy: utopia or achievable prospect? Risk information, risk research and advocacy in Teratology Information Services. Congenit Anom (Kyoto) 51:6\u201311","journal-title":"Congenit Anom (Kyoto)"},{"key":"1231_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.17826\/cumj.490997","volume":"44","author":"D Altintas Aykan","year":"2019","unstructured":"Altintas Aykan D, Ergun Y (2019) Reliability of cardiovascular drug use in pregnancy with clinical pharmacology teratology risk analysis. Cukurova Med J 44:1\u20131","journal-title":"Cukurova Med J"},{"key":"1231_CR6","doi-asserted-by":"publisher","first-page":"50","DOI":"10.14744\/etd.2018.18176","volume":"41","author":"D Altintas Aykan","year":"2019","unstructured":"Altintas Aykan D, Ergun Y (2019) Hormonal contraceptives: what if exposed during pregnancy? Erci Med J 41:50\u201355. https:\/\/doi.org\/10.14744\/etd.2018.18176","journal-title":"Erci Med J"},{"key":"1231_CR7","doi-asserted-by":"publisher","first-page":"751","DOI":"10.5455\/annalsmedres.2018.07.140","volume":"25","author":"D Altintas Aykan","year":"2018","unstructured":"Altintas Aykan D, Ergun Y (2018) Teratogenic evaluation of drugs used by pregnant patients with gastrointestinal system diseases. Ann Med Res 25:751\u2013755. https:\/\/doi.org\/10.5455\/annalsmedres.2018.07.140","journal-title":"Ann Med Res"},{"key":"1231_CR8","doi-asserted-by":"publisher","first-page":"646","DOI":"10.5455\/annalsmedres.2018.12.279","volume":"26","author":"D Altintas Aykan","year":"2019","unstructured":"Altintas Aykan D, Ergun Y (2019) Maternal antibiotic exposure and fetal outcomes: is there evidence for teratogenicity? Ann Med Res 26:646\u2013652. https:\/\/doi.org\/10.5455\/annalsmedres.2018.12.279","journal-title":"Ann Med Res"},{"key":"1231_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1242\/dmm.035600","volume":"11","author":"E Kelly","year":"2018","unstructured":"Kelly E, Sharma D, Wilkinson CJ, Williams RSB (2018) Diacylglycerol kinase (DGKA) regulates the effect of the epilepsy and bipolar disorder treatment valproic acid in Dictyostelium discoideum. Dis Model Mech 11:9","journal-title":"Dis Model Mech"},{"key":"1231_CR10","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1111\/ppe.12004","volume":"26","author":"WV Bobo","year":"2012","unstructured":"Bobo WV, Davis RL, Toh S et al (2012) Trends in the use of antiepileptic drugs among pregnant women in the US, 2001\u20132007: a medication exposure in pregnancy risk evaluation program study. Paediatr Perinat Epidemiol 26:578\u2013588","journal-title":"Paediatr Perinat Epidemiol"},{"key":"1231_CR11","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1002\/pds.3847","volume":"24","author":"R Charlton","year":"2015","unstructured":"Charlton R, Garne E, Wang H et al (2015) Antiepileptic drug prescribing before, during and after pregnancy: a study in seven European regions. Pharmacoepidemiol Drug Saf 24:1144\u20131154","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1231_CR12","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.seizure.2015.02.019","volume":"28","author":"T Tomson","year":"2015","unstructured":"Tomson T, Xue H, Battino D (2015) Major congenital malformations in children of women with epilepsy. Seizure 28:46\u201350","journal-title":"Seizure"},{"key":"1231_CR13","doi-asserted-by":"publisher","first-page":"505","DOI":"10.2147\/IJWH.S98973","volume":"8","author":"LM Borgelt","year":"2016","unstructured":"Borgelt LM, Hart FM, Bainbridge JL (2016) Epilepsy during pregnancy: focus on management strategies. Int J Womens Health 8:505\u2013517","journal-title":"Int J Womens Health"},{"key":"1231_CR14","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S1474-4422(11)70107-7","volume":"10","author":"T Tomson","year":"2011","unstructured":"Tomson T, Battino D, Bonizzoni E et al (2011) Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. Lancet Neurol 10:609\u2013617","journal-title":"Lancet Neurol"},{"key":"1231_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.reprotox.2009.02.014","volume":"28","author":"A Ornoy","year":"2009","unstructured":"Ornoy A (2009) Valproic acid in pregnancy: how much are we endangering the embryo and fetus? Reprod Toxicol 28:1\u201310","journal-title":"Reprod Toxicol"},{"key":"1231_CR16","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1136\/jnnp-2013-306318","volume":"85","author":"E Campbell","year":"2014","unstructured":"Campbell E, Kennedy F, Russell A et al (2014) Malformation risks of antiepileptic drug monotherapies in pregnancy: updated results from the UK and Ireland epilepsy and pregnancy registers. J Neurol Neurosurg Psychiatry 85:1029\u20131034","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1231_CR17","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/S1474-4422(18)30107-8","volume":"17","author":"T Tomson","year":"2018","unstructured":"Tomson T, Battino D, Bonizzoni E et al (2018) EURAP study group. Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry. Lancet Neurol 17:530\u2013538","journal-title":"Lancet Neurol"},{"key":"1231_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.eplepsyres.2008.04.022","volume":"81","author":"K Meador","year":"2008","unstructured":"Meador K, Reynolds MW, Crean S, Fahrbach K, Probst C (2008) Pregnancy outcomes in women with epilepsy: a systematic review and metaanalysis of published pregnancy registries and cohorts. Epilepsy Res 81:1\u201313","journal-title":"Epilepsy Res"},{"key":"1231_CR19","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/ane.12280","volume":"130","author":"FJ Vajda","year":"2014","unstructured":"Vajda FJ, O\u2019Brien TJ, Lander CM, Graham J, Eadie MJ (2014) The teratogenicity of the newer antiepileptic drugs\u2014an update. Acta Neurol Scand 130:234\u2013238","journal-title":"Acta Neurol Scand"},{"key":"1231_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/pds.4749","author":"T Ishikawa","year":"2019","unstructured":"Ishikawa T, Obara T, Jin K et al (2019) Examination of the prescription of antiepileptic drugs to prenatal and postpartum women in Japan from a health administrative database. Pharmacoepidemiol Drug Saf. https:\/\/doi.org\/10.1002\/pds.4749","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1231_CR21","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s40263-018-0517-5","volume":"32","author":"P Damkier","year":"2018","unstructured":"Damkier P, Videbech P (2018) The safety of second-generation antipsychotics during pregnancy: a clinically focused review. CNS Drugs 32:351\u2013366. https:\/\/doi.org\/10.1007\/s40263-018-0517-5","journal-title":"CNS Drugs"},{"key":"1231_CR22","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/BOR.0000000000000054","volume":"26","author":"BL Bermas","year":"2014","unstructured":"Bermas BL (2014) Non-steroidal anti inflammatory drugs, glucocorticoids and disease modifying anti-rheumatic drugs for the management of rheumatoid arthritis before and during pregnancy. Curr Opin Rheumatol 26:334\u2013340. https:\/\/doi.org\/10.1097\/BOR.0000000000000054","journal-title":"Curr Opin Rheumatol"},{"key":"1231_CR23","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1111\/j.1528-1167.2009.02130.x","volume":"50","author":"CL Harden","year":"2009","unstructured":"Harden CL, Pennell PB, Koppel BS, American Academy of Neurology; American Epilepsy Society et al (2009) Management issues for women with epilepsy\u2013focus on pregnancy (an evidence-based review): III. Vitamin K, folic acid, blood levels, and breast-feeding: Report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Epilepsia 50:1247\u20131255","journal-title":"Epilepsia"},{"key":"1231_CR24","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.yebeh.2016.03.034","volume":"59","author":"YT Lu","year":"2016","unstructured":"Lu YT, Hsu CW, Tsai WC et al (2016) Status epilepticus associated with pregnancy: a cohort study. Epilepsy Behav 59:92\u201397. https:\/\/doi.org\/10.1016\/j.yebeh.2016.03.034","journal-title":"Epilepsy Behav"},{"key":"1231_CR25","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.pedneo.2016.01.009","volume":"58","author":"H Mutlu-Albayrak","year":"2017","unstructured":"Mutlu-Albayrak H, Bulut C, \u00c7aksen H (2017) Fetal Valproate Syndrome. Pediatr Neonatol 58:158\u2013164","journal-title":"Pediatr Neonatol"}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-019-01231-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13760-019-01231-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-019-01231-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,14]],"date-time":"2021-03-14T18:04:42Z","timestamp":1615745082000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13760-019-01231-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,28]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["1231"],"URL":"https:\/\/doi.org\/10.1007\/s13760-019-01231-2","relation":{},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"type":"print","value":"0300-9009"},{"type":"electronic","value":"2240-2993"}],"subject":[],"published":{"date-parts":[[2019,10,28]]},"assertion":[{"value":"2 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}